医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
12期
91-92
,共2页
联合药物%诱导%DSA%出血%介入栓塞
聯閤藥物%誘導%DSA%齣血%介入栓塞
연합약물%유도%DSA%출혈%개입전새
combined drug%inducing%DSA%bleeding%interventional embolization
目的探讨联合药物诱导DSA在小肠隐匿性出血的临床应用的可行性、安全性、有效性.方法对11例常规DSA不能明确病因的小肠隐匿性出血患者,给予联合药物(尿激酶+罂粟碱)诱导DSA检查,对小肠隐匿性出血定位定性诊断,同时给予介入栓塞治疗.结果11例患者经联合药物诱导DSA检查明确小肠出血部位、性质,并给予介入栓塞止血,与外科手术病理结论相一致.结论联合药物诱导DSA在小肠隐匿性出血诊疗中的临床应用是可行的、安全的、有效的,对小肠隐匿性出血定位定性诊疗中有重要临床应用价值.
目的探討聯閤藥物誘導DSA在小腸隱匿性齣血的臨床應用的可行性、安全性、有效性.方法對11例常規DSA不能明確病因的小腸隱匿性齣血患者,給予聯閤藥物(尿激酶+罌粟堿)誘導DSA檢查,對小腸隱匿性齣血定位定性診斷,同時給予介入栓塞治療.結果11例患者經聯閤藥物誘導DSA檢查明確小腸齣血部位、性質,併給予介入栓塞止血,與外科手術病理結論相一緻.結論聯閤藥物誘導DSA在小腸隱匿性齣血診療中的臨床應用是可行的、安全的、有效的,對小腸隱匿性齣血定位定性診療中有重要臨床應用價值.
목적탐토연합약물유도DSA재소장은닉성출혈적림상응용적가행성、안전성、유효성.방법대11례상규DSA불능명학병인적소장은닉성출혈환자,급여연합약물(뇨격매+앵속감)유도DSA검사,대소장은닉성출혈정위정성진단,동시급여개입전새치료.결과11례환자경연합약물유도DSA검사명학소장출혈부위、성질,병급여개입전새지혈,여외과수술병리결론상일치.결론연합약물유도DSA재소장은닉성출혈진료중적림상응용시가행적、안전적、유효적,대소장은닉성출혈정위정성진료중유중요림상응용개치.
Objective To evaluate the clinical feasibility,safety,and effectiveness of DSA of combined drug inducing for smal intestine dormant bleeding.Methods DSA of combined drug(Urokinase+Papaverine) inducing was performed in 11 patients with smal intestine dormant bleeding that wasn’t obviously showed by general DSA,by this way ,smal intestine dormant bleeding was found out,and at the same time it was contoled by interventional artery embolization.Results 11 patients ’arteriolar bleeding were found out and were embolized successfuliy,. Conclusion DSA of combined drug inducing is clinicaly feasible,safe and effective in gastroenteric aterial bleeding,it is important value in the course of clinical application for smal intestine dormant bleeding.
